Drug · DIN 02548593
LURASIDONE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since December 17, 2024; first marketed December 17, 2024.
- Drug Identification Number (DIN)
- 02548593
- Company (DIN owner)
- Sanis Health Inc.Brampton, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Lurasidone N05AE05
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| LURASIDONE HYDROCHLORIDE | 40 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 13, 2024: NOC 33441Abbreviated New Drug Submission (ANDS) · Administrative: Licensing Agreement Between Two Manufacturers
Other DINs named LURASIDONE
- DIN 02548585 · Marketed
- DIN 02548607 · Marketed
- DIN 02548615 · Marketed
- DIN 02548623 · Approved